Global Heparin Market Size By Type(Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin), By Application(Venous Thromboembolism, Atrial Fibrillation, Renal Impairment), By Geographic Scope and Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Heparin Market size was valued at USD 9.47 Billion in 2022 and is projected to reach USD 12.71 Billion by 2030, growing at a CAGR of 3.75% from 2024 to 2030.
So, what's driving the global market for heparin? Well, things like more people dealing with conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE) are definitely playing a big role. Plus, with the world's population getting older, and more demand coming from emerging markets, it's no surprise. Of course, there are other things to keep an eye on too, like new rules and regulations, patents running out, and other alternative anticoagulant drugs trying to compete. All in all, it looks like the heparin market will keep growing as we need more ways to prevent blood clots. But, you know, there are always potential bumps in the road, like the ongoing COVID-19 pandemic and worries about whether heparin is always safe and works as well as we hope.
Global Heparin Market Definition
So, heparin is a common blood thinner, or anticoagulant, used to prevent and treat clots. You might hear it called ordinary or unfractionated heparin (UFH). One brand name you might recognize is Hep-Lock. It basically stops clots from forming and is usually given as a shot. You'll find heparin used all over – in hospitals, clinics, even at home. Doctors often prescribe heparin to folks with specific health issues or those undergoing procedures, like surgery, where the risk of clots goes up. Think of a heparin injection as something that helps your blood flow smoothly, reducing its ability to clot and preventing dangerous clots from forming in your blood vessels.
What's inside a industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Heparin Market Overview
The Heparin Market is expanding mostly because of the rising incidence of blood clotting problems, while other factors such as heparin’s adverse effects could slow this expansion
Okay, so one of the big reasons the heparin market is growing? It's because we're seeing more and more chronic diseases. Think cardiovascular disease, kidney problems, and inflammatory issues – they're becoming super common. What's fueling this? Things like being overweight, skipping exercise, eating junk food, drinking too much, and smoking. In fact, some predict a whopping 25% of Americans will be dealing with extreme obesity by 2030. This rise in obesity and related health issues is leading to more cardiovascular problems like deep vein thrombosis and pulmonary embolism, which are both signs of something called venous thromboembolism. The CDC estimates that around 900,000 people in the United States might experience venous thromboembolism every year!
It seems like we're seeing more and more people worldwide facing issues with their blood's ability to clot properly. Things like Von Willebrand disease, hemophilia, deep vein thrombosis, hypercoagulable states, and clotting factor deficiencies are on the rise. Just to give you an idea, the CDC reported that around 400 babies are born with hemophilia each year in the US. And back in February 2020, they also said that almost 900,000 Americans are affected by DVT/PE, or venous thromboembolism, annually. Because these coagulation problems are becoming so much more common, we need to keep a close eye on things and get ready for an increase in medical treatments. This, in turn, is really driving the growth of the global heparin market. Plus, doctors often recommend coagulation tests before major surgeries.
One big problem slowing down the global growth of products made from pigs is that we're not getting enough raw materials from China. Take what happened in July 2020, for instance. According to someone at China's agriculture ministry, they were still having a tough time controlling African swine flu. They'd reported more than 11 outbreaks and even found new versions of the virus. ASF is really bad news for pigs – it’s usually fatal. To stop it from spreading, they've had to cull a lot of pigs, especially with the latest outbreaks hitting northern China. Another issue holding things back is the high cost of LMWH. That could stop it from becoming more popular in poorer countries, and honestly, it's likely to. Read more here.
Global Heparin Market Segmentation Analysis
The Global Heparin Market is segmented based on Type, Application, And Geography.
Heparin Market By Type
Low Molecular Weight Heparin
Ultra-low Molecular Weight Heparin
Unfractionated Heparin
The LMWH market segment dominated the worldwide heparin market. The high rate of product acceptance in developed markets and the superior safety profiles of these goods compared to competing ones account for the segment’s dominance. Fragmin (Dalteparin sodium), Lovenox (Enoxaparin sodium), and Innohep are a few crucial LMWH medications (Tinzaparin sodium). Several industry participants are also concentrating on the creation and introduction of fresh LMWH goods on the international market. For instance, Valeo Pharma Inc. reported in November 2019 that it had submitted a New Drug Submission for an LMWH biosimilar, which Health Canada has accepted for assessment.
Heparin Market By Application
Venous Thromboembolism
Atrial Fibrillation
Renal Impairment
Coronary Artery Disease
Others
So, when we talk about the global heparin market, we can break it down by what it's used for. Heparin's a popular anticoagulant, mainly for preventing and treating blood clots. That means a big chunk of the market focuses on treating thrombosis and similar problems, like deep vein thrombosis (DVT), pulmonary embolism (PE), and other venous thromboembolism (VTE) conditions. Another major use is in hemodialysis – they use it to stop the dialysis machine and tubing from clotting up during treatment. Plus, you'll find it in other medical procedures like heart surgeries and angioplasty to prevent clotting and lower the chance of heart attacks and strokes. Believe it or not, heparin even pops up in the cosmetic industry as an anti-aging ingredient in some skincare stuff! The idea is that it's good for your skin, helping to smooth out wrinkles and other signs of aging.
Heparin Market by Geography
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
When it comes to the global market, North America is expected to take the lion's share. Why? Well, the region faces a high rate of cardiovascular diseases, like pulmonary embolism, and they're quick to adopt cutting-edge goods. Plus, healthcare spending is high, and major players in the sales of these products are already there. For example, the CDC estimated back in October 2022 that around 805,000 Americans have a heart attack annually, and a whopping 605,000 of those are new cases. Europe isn't far behind, predicted to be the second-largest market, thanks to its embrace of advanced tech and the growing number of folks dealing with various cardiovascular issues. Think about ita British government report from February 2022 stated that venous thrombosis affects roughly 1 in every 1,000 people in the UK each year.
Key Players
The major players in the market are; Pfizer Inc., Leo Pharma A/S, Dr.Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Techdow USA Inc, Sanofi, Optimvia Pharmaceuticals, Aspen Holdings, Fresenius SE & Co. KGaA, B Braun Medical Inc., Sandoz, Gland Pharma among others.This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.
Key Developments
In February 2022, Heparin Sodium Injection was introduced on the market in the United States by Techdow USA Inc.
In January 2022, Optimvia Pharmaceuticals, an Ohio-based biotechnology business, asserted to have created a synthetic process for producing huge quantities of heparin, which is required to generate a common blood thinner, at a competitive price.
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2020-2030
BASE YEAR
2023
FORECAST PERIOD
2024-2030
HISTORICAL PERIOD
2020-2022
UNIT
Value (USD Billion)
KEY COMPANIES PROFILED
Pfizer Inc., Leo Pharma A/S, Dr.Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Techdow USA Inc, Sanofi, Optimvia Pharmaceuticals, Aspen Holdings, Fresenius SE & Co. KGaA, B Braun Medical Inc., Sandoz, Gland Pharma among others.
SEGMENTS COVERED
By Type, By Application, And By Geography.
CUSTOMIZATION SCOPE
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
We dive deep, looking at the market from all angles – both the money side (quantitative) and the less obvious, human side (qualitative). We break things down by segmentation, using both economic and non-economic stuff. You'll get market value numbers in USD Billion for every segment and sub-segment. We'll point out which region and segment we think will grow the fastest and which will be the biggest. We also analyze each geographical area, focusing on how the product/service is being used and what's influencing the market there. Think of it as a region-by-region breakdown. We'll also give you a competitive landscape, showing where the big players rank, plus any new products, partnerships, expansions, or acquisitions from the last five years. Speaking of players, we'll have extensive company profiles with overviews, insights, product comparisons, and even a SWOT analysis for each major company. We'll also give you the current and future market outlook, considering recent events, growth opportunities, drivers, and challenges in both emerging and established regions. We’ll use Porter's five forces analysis to give you a comprehensive look at the market. Plus, we offer market insight through a Value Chain perspective. You'll get a good feel for the market dynamics and the growth opportunities headed your way. And don't forget, you get 6 months of analyst support after your purchase. Learn more here.
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for Global Heparin Market Size By Type(Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin), By Application(Venous Thromboembolism, Atrial Fibrillation, Renal Impairment), By Geographic Scope and Forecast
